Increased risk of hyperglycemia of hypoglycemia if changes in physical activity, meal patterns, concomitant medications, renal or hepatic function, insulin regimen, administration site ...

Many patients pay for insulin based on a percentage of the drug’s list price, not the discounted price. The higher the list price, the more unaffordable the drug becomes, regardless of the discount ...

This “recombinant insulin” first came on the market in the mid-1980s, under the brand name Humulin. After its release, Humulin quickly replaced traditional sources of insulin. Today, almost all ...

Then, I compared 14 plans that have the same name across the country ... in the coverage of these drugs, which becomes an important concern for those who need insulin. There are probably 12 ...

The agency's suit argues that the three PBMs have created a "perverse" drug rebate system that prioritizes high rebates from ...

“Although not named in this case, all drug manufacturers should be ... adding that the company has not raised list prices for ...

Toni, I received my new 2025 Part D premium with the plan increase going up by 250%, from $25 a month to over $60.

At the center of this fight is how the FDA regulates a possible "functional cure" for Type 1 diabetes and determines who gets ...

In particular, the agency argued that the rebate practices of Caremark, Express Scripts, and OptumRx caused the list prices of insulin drugs to be artificially high and limited patients' access to ...

Lexicon Pharmaceuticals shares have been halted all day as a Food and Drug Administration advisory committee was scheduled to vote on Zynquista as an adjunct to insulin therapy for glycemic control in ...

Drugs such as Wegovy, Ozempic, and Saxenda have quickly become household names. But are these weight loss medications right ...

Insulin 6x is a single ingredient drug in this case and writing ‘Insulin Tablets’ on the label imitating it as a proprietary name was in violation of the Drugs and Cosmetics Rules, 1945.